MicroRNA and gynecologic cancers

Aim Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic cancers and use of miRNA profiles for diagnosis of diseases. Methods In order to obtain information needed for this review, we searched th...

Full description

Saved in:
Bibliographic Details
Published inThe journal of obstetrics and gynaecology research Vol. 42; no. 6; pp. 612 - 617
Main Authors Kanekura, Kohsuke, Nishi, Hirotaka, Isaka, Keiichi, Kuroda, Masahiko
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.06.2016
Subjects
Biomarkers - blood
cervical cancer
endometrial cancer
Endometrial Neoplasms - diagnosis
Endometrial Neoplasms - genetics
Endometrial Neoplasms - metabolism
Female
Genital Neoplasms, Female - diagnosis
Genital Neoplasms, Female - genetics
Genital Neoplasms, Female - metabolism
Humans
MicroRNAs - genetics
MicroRNAs - metabolism
miRNA
ovarian cancer
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - genetics
Uterine Cervical Neoplasms - metabolism
endometrial cancer
miRNA
ovarian cancer
cervical cancer
Online AccessGet full text

Cover

Abstract Aim Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic cancers and use of miRNA profiles for diagnosis of diseases. Methods In order to obtain information needed for this review, we searched the PubMed database with the following keywords: miRNA and ovarian cancer; miRNA and cervical cancer; and miRNA and endometrial cancer. Results Recent explosive investigations in the field have dramatically expanded our knowledge of the roles of miRNA in the pathology of gynecologic malignancies. In ovarian cancer, miRNA participates in the development of drug resistance. In cervical cancer and endometrial cancer, miRNA play essential roles in important oncogenic processes, including cell proliferation, migration and metastasis. miRNA also have high potentials to be used as biomarkers in these diseases. Conclusion Further validation of the studies and improvement of the methods will result in the broader use of miRNA in the diagnosis of diseases as well as in understanding of the pathomechanisms of gynecologic cancers.
AbstractList Abstract Aim Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic cancers and use of miRNA profiles for diagnosis of diseases. Methods In order to obtain information needed for this review, we searched the PubMed database with the following keywords: miRNA and ovarian cancer; miRNA and cervical cancer; and miRNA and endometrial cancer. Results Recent explosive investigations in the field have dramatically expanded our knowledge of the roles of miRNA in the pathology of gynecologic malignancies. In ovarian cancer, miRNA participates in the development of drug resistance. In cervical cancer and endometrial cancer, miRNA play essential roles in important oncogenic processes, including cell proliferation, migration and metastasis. miRNA also have high potentials to be used as biomarkers in these diseases. Conclusion Further validation of the studies and improvement of the methods will result in the broader use of miRNA in the diagnosis of diseases as well as in understanding of the pathomechanisms of gynecologic cancers.
AIMGynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic cancers and use of miRNA profiles for diagnosis of diseases.METHODSIn order to obtain information needed for this review, we searched the PubMed database with the following keywords: miRNA and ovarian cancer; miRNA and cervical cancer; and miRNA and endometrial cancer.RESULTSRecent explosive investigations in the field have dramatically expanded our knowledge of the roles of miRNA in the pathology of gynecologic malignancies. In ovarian cancer, miRNA participates in the development of drug resistance. In cervical cancer and endometrial cancer, miRNA play essential roles in important oncogenic processes, including cell proliferation, migration and metastasis. miRNA also have high potentials to be used as biomarkers in these diseases.CONCLUSIONFurther validation of the studies and improvement of the methods will result in the broader use of miRNA in the diagnosis of diseases as well as in understanding of the pathomechanisms of gynecologic cancers.
Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic cancers and use of miRNA profiles for diagnosis of diseases. In order to obtain information needed for this review, we searched the PubMed database with the following keywords: miRNA and ovarian cancer; miRNA and cervical cancer; and miRNA and endometrial cancer. Recent explosive investigations in the field have dramatically expanded our knowledge of the roles of miRNA in the pathology of gynecologic malignancies. In ovarian cancer, miRNA participates in the development of drug resistance. In cervical cancer and endometrial cancer, miRNA play essential roles in important oncogenic processes, including cell proliferation, migration and metastasis. miRNA also have high potentials to be used as biomarkers in these diseases. Further validation of the studies and improvement of the methods will result in the broader use of miRNA in the diagnosis of diseases as well as in understanding of the pathomechanisms of gynecologic cancers.
Aim Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic cancers and use of miRNA profiles for diagnosis of diseases. Methods In order to obtain information needed for this review, we searched the PubMed database with the following keywords: miRNA and ovarian cancer; miRNA and cervical cancer; and miRNA and endometrial cancer. Results Recent explosive investigations in the field have dramatically expanded our knowledge of the roles of miRNA in the pathology of gynecologic malignancies. In ovarian cancer, miRNA participates in the development of drug resistance. In cervical cancer and endometrial cancer, miRNA play essential roles in important oncogenic processes, including cell proliferation, migration and metastasis. miRNA also have high potentials to be used as biomarkers in these diseases. Conclusion Further validation of the studies and improvement of the methods will result in the broader use of miRNA in the diagnosis of diseases as well as in understanding of the pathomechanisms of gynecologic cancers.
Author Kanekura, Kohsuke
Isaka, Keiichi
Kuroda, Masahiko
Nishi, Hirotaka
Author_xml – sequence: 1
  givenname: Kohsuke
  surname: Kanekura
  fullname: Kanekura, Kohsuke
  email: kanekura@tokyo-med.ac.jp
  organization: Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan
– sequence: 2
  givenname: Hirotaka
  surname: Nishi
  fullname: Nishi, Hirotaka
  organization: Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan
– sequence: 3
  givenname: Keiichi
  surname: Isaka
  fullname: Isaka, Keiichi
  organization: Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan
– sequence: 4
  givenname: Masahiko
  surname: Kuroda
  fullname: Kuroda, Masahiko
  organization: Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27098274$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtOwkAUhicGIxdd-AKmS10U5trpLAnRqkEwxEviZjKdmZJiabEDUd7ewQI7z-acxff_Ofm6oFVWpQXgEsE-8jNYVPM-wkKwE9BBlPIQcha1_E0oCmPIozboOreAEHGB4jPQxhyKGHPaAcFTrutqNhkGqjTBfFtaXRXVPNeBVqW2tTsHp5kqnL3Y7x54vbt9Gd2H42nyMBqOQ00ZYSEjwqSYRoZRgyMOIyWsEjozFFttYhthywxVNGYspUTv0AwRiClPGeQWkh64bnpXdfW1sW4tl7nTtihUaauNk_51wiLBOfLoTYP6z52rbSZXdb5U9VYiKHdCpBci_4R49mpfu0mX1hzJgwEPDBrgOy_s9v8m-ThNDpVhk8jd2v4cE6r-lBEnnMn3SSL5RxJT8fYsZ-QXP5h4eA
CitedBy_id crossref_primary_10_1042_BSR20170347
crossref_primary_10_1002_kjm2_12109
crossref_primary_10_3892_etm_2019_7713
crossref_primary_10_3892_ol_2019_10470
crossref_primary_10_1016_j_gore_2023_101138
crossref_primary_10_1016_j_bjorl_2023_03_003
crossref_primary_10_1186_s12891_023_06473_z
crossref_primary_10_18632_aging_103037
crossref_primary_10_3390_ijms23116210
crossref_primary_10_3233_CBM_190575
crossref_primary_10_3390_cells11111836
crossref_primary_10_3892_mmr_2020_11466
crossref_primary_10_3727_096504017X15140534417184
crossref_primary_10_3892_ol_2018_9603
crossref_primary_10_18632_oncotarget_14307
crossref_primary_10_3390_cells11010075
crossref_primary_10_3390_ijms22063280
crossref_primary_10_3389_fgene_2021_679643
crossref_primary_10_2147_OTT_S246841
crossref_primary_10_2174_1574893617666220802154148
crossref_primary_10_3892_ol_2019_10403
crossref_primary_10_2174_2211536608666191026115045
crossref_primary_10_7759_cureus_31549
Cites_doi 10.1186/2050-7771-1-12
10.1038/nature03552
10.1016/0092-8674(93)90384-3
10.1128/jvi.67.5.2521-2528.1993
10.1038/nrm3567
10.1016/j.molcel.2009.08.017
10.1038/sj.onc.1209429
10.1073/pnas.1401430111
10.1093/nar/gki567
10.1210/me.2011-1037
10.1016/j.surg.2012.12.004
10.3892/or.2013.2527
10.1074/jbc.M900843200
10.1016/j.cell.2008.02.019
10.1073/pnas.96.12.6999
10.1159/000214919
10.1007/BF02256414
10.1080/10428190601059738
10.1186/2162-3619-3-14
10.1371/journal.pone.0035158
10.1038/ncb2099
10.1007/s00404-013-2784-1
10.1074/jbc.M608939200
10.1016/j.tem.2012.03.002
10.1016/j.ydbio.2007.08.007
10.1016/j.ygyno.2012.12.043
10.1371/journal.pone.0090810
10.1021/bi026980c
10.1101/gad.1399806
10.1038/ncomms3977
10.1074/jbc.R115.667931
10.1371/journal.pone.0070202
10.1113/JP270318
10.1373/clinchem.2015.241190
10.1126/science.2537532
10.1016/j.coi.2005.11.006
10.1128/JVI.76.23.12162-12172.2002
10.1016/j.ygyno.2008.08.036
10.1210/en.2011-2123
10.1002/14651858.CD011732.pub2
10.1158/1078-0432.CCR-11-2485
10.1095/biolreprod.109.081059
10.1016/j.ajog.2014.06.036
10.7314/APJCP.2013.14.4.2289
10.1073/pnas.0906947106
10.1007/s00432-012-1147-9
10.4161/cbt.11.8.14967
10.1186/1757-2215-4-17
10.1016/j.ygyno.2014.08.023
10.1128/JVI.01318-08
10.1158/0008-5472.CAN-05-2352
10.1073/pnas.0508889103
10.1016/j.ygyno.2008.04.033
10.1159/000012033
10.1128/MCB.00242-06
10.3892/or.2014.3142
ContentType Journal Article
Copyright 2016 Japan Society of Obstetrics and Gynecology
2016 Japan Society of Obstetrics and Gynecology.
Copyright_xml – notice: 2016 Japan Society of Obstetrics and Gynecology
– notice: 2016 Japan Society of Obstetrics and Gynecology.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1111/jog.12995
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1447-0756
EndPage 617
ExternalDocumentID 10_1111_jog_12995
27098274
JOG12995
ark_67375_WNG_7ZG849VP_R
Genre miscellaneous
Journal Article
Review
GrantInformation_xml – fundername: Japan Society for the promotion of Science
  funderid: 15 K15100
– fundername: Ministry of Education, Culture, Sports, Science and Technology
  funderid: S1511011
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4535-539db246d54d26706a9ea9cfd42ecd8e62e5d4a4855b43cb246f130247b507e03
IEDL.DBID DR2
ISSN 1341-8076
IngestDate Fri Aug 16 04:03:30 EDT 2024
Fri Aug 23 01:13:55 EDT 2024
Sat Sep 28 08:07:51 EDT 2024
Sat Aug 24 00:54:39 EDT 2024
Wed Oct 30 09:52:57 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords endometrial cancer
miRNA
ovarian cancer
cervical cancer
Language English
License 2016 Japan Society of Obstetrics and Gynecology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4535-539db246d54d26706a9ea9cfd42ecd8e62e5d4a4855b43cb246f130247b507e03
Notes Ministry of Education, Culture, Sports, Science and Technology - No. S1511011
istex:7DF114E46F0B94A22954A9FEC2558E3810A59FA9
Japan Society for the promotion of Science - No. 15 K15100
ArticleID:JOG12995
ark:/67375/WNG-7ZG849VP-R
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 27098274
PQID 1793569771
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1793569771
crossref_primary_10_1111_jog_12995
pubmed_primary_27098274
wiley_primary_10_1111_jog_12995_JOG12995
istex_primary_ark_67375_WNG_7ZG849VP_R
PublicationCentury 2000
PublicationDate June 2016
PublicationDateYYYYMMDD 2016-06-01
PublicationDate_xml – month: 06
  year: 2016
  text: June 2016
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle The journal of obstetrics and gynaecology research
PublicationTitleAlternate J. Obstet. Gynaecol. Res
PublicationYear 2016
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Zhao YN, Chen GS, Hong SJ. Circulating MicroRNAs in gynecological malignancies: From detection to prediction. Exp Hematol Oncol 2014; 3: 14.
Jiang Q, Greenberg RA. Deciphering the BRCA1 tumor suppressor network. J Biol Chem 2015; 290: 17724-17732.
Schwarz JK, Payton JE, Rashmi R et al. Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer. Clin Cancer Res 2012; 18: 1464-1471.
Yamagata K, Fujiyama S, Ito S et al. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol Cell 2009; 36: 340-347.
Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-505.
Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 2007; 310: 442-453.
Kong X, Xu X, Yan Y et al. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One 2014; 9: e90810.
Zhao S, Yao DS, Chen JY, Ding N. Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac J Cancer Prev 2013; 14: 2289-2293.
Romero I, Bast RC Jr. Minireview: Human ovarian cancer: Biology, current management, and paths to personalizing therapy. Endocrinology 2012; 153: 1593-1602.
Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-59.
Kietpeerakool C, Supoken A, Laopaiboon M, Lumbiganon P. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer. Cochrane Database Syst Rev 2016; 1 .CD011732
Burk RD, Chen Z, Van Doorslaer K. Human papillomaviruses: Genetic basis of carcinogenicity. Public Health Genomics 2009; 12: 281-290.
Lorenzen JM. Vascular and circulating microRNAs in renal ischaemia-reperfusion injury. J Physiol 2015; 593: 1777-1784.
Gao M, Sun PM, Wang JL, Li XP, Zhao C, Wei LH. Different biological effect of estrogen receptor-related receptor alpha in estrogen receptor-positive and -negative endometrial carcinoma. Mol Med Rep 2008; 1: 917-924.
Yang MH, Hsu DS, Wang HW et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982-992.
Rinaldi A, Poretti G, Kwee I et al. Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leuk Lymphoma 2007; 48: 410-412.
Zhang L, Huang J, Yang N et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 2006; 103: 9136-9141.
Karaayvaz M, Zhang C, Liang S, Shroyer KR, Ju J. Prognostic significance of miR-205 in endometrial cancer. PLoS One 2012; 7: e35158.
Schuler S, Ponnath M, Engel J, Ortmann O. Ovarian epithelial tumors and reproductive factors: A systematic review. Arch Gynecol Obstet 2013; 287: 1187-1204.
Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Prognostic significance of miR-194 in endometrial cancer. Biomark Res 2013; 1: 12.
Hayashita Y, Osada H, Tatematsu Y et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-9632.
Berezutskaya E, Yu B, Morozov A, Raychaudhuri P, Bagchi S. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ 1997; 8: 1277-1286.
Liu X, Dakic A, Chen R et al. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc. J Virol 2008; 82: 11568-11576.
Tang T, Wong HK, Gu W et al. MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol Oncol 2013; 129: 199-208.
Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
Mor G, Yin G, Chefetz I, Yang Y, Alvero A. Ovarian cancer stem cells and inflammation. Cancer Biol Ther 2011; 11: 708-713.
Zhang H, Liu CY, Zha ZY et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 2009; 284: 13355-13362.
Klinge CM. miRNAs and estrogen action. Trends Endocrinol Metab 2012; 23: 223-233.
Vallen MJ, van der Steen SC, van Tilborg AA, Massuger LF, van Kuppevelt TH. Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: 'When sweet turns sour'. Gynecol Oncol 2014; 135: 371-381.
Kabsch K, Alonso A. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol 2002; 76: 12162-12172.
Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N, Pollard JW. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod 2010; 82: 791-801.
Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006; 18: 39-48.
Smith-McCune K, Kalman D, Robbins C, Shivakumar S, Yuschenkoff L, Bishop JM. Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130. Proc Natl Acad Sci U S A 1999; 96: 6999-7004.
Foti E, Ferrandina G, Martucci R et al. IL-6, M-CSF and IAP cytokines in ovarian cancer: Simultaneous assessment of serum levels. Oncology 1999; 57: 211-215.
He Y, Lin J, Kong D et al. Current state of circulating microRNAs as cancer biomarkers. Clin Chem 2015; 61: 1138-1155.
Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
Wang X, Wang HK, Li Y et al. microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 2014; 111: 4262-4267.
Nishi H, Kuroda M, Isaka K. Estrogen and estrogen receptor induce matrix metalloproteinase-26 expression in endometrial carcinoma cells. Oncol Rep 2013; 30: 751-756.
Luo M, Shen D, Zhou X, Chen X, Wang W. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013; 153: 836-847.
Chang JL, Tsao YP, Liu DW, Huang SJ, Lee WH, Chen SL. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix. J Biomed Sci 2001; 8: 206-213.
Nomine Y, Charbonnier S, Ristriani T et al. Domain substructure of HPV E6 oncoprotein: Biophysical characterization of the E6 C-terminal DNA-binding domain. Biochemistry 2003; 42: 4909-4917.
Qian K, Pietila T, Ronty M et al. Identification and validation of human papillomavirus encoded microRNAs. PLoS One 2013; 8: e70202.
Castellano L, Giamas G, Jacob J et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A 2009; 106: 15732-15737.
Davies R, Hicks R, Crook T, Morris J, Vousden K. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 1993; 67: 2521-2528.
Ruterbusch JJ, Ali-Fehmi R, Olson SH et al. The influence of comorbid conditions on racial disparities in endometrial cancer survival. Am J Obstet Gynecol 2014; 211: 627e1-627e9.
Ventura A, Young AG, Winslow MM et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875-886.
Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110: 13-21.
Dick FA, Rubin SM. Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol 2013; 14: 297-306.
Tanzer A, Stadler PF. Evolution of microRNAs. Methods Mol Biol 2006; 342: 335-350.
Kumar S, Kumar A, Shah PP, Rai SN, Panguluri SK, Kakar SS. MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines. J Ovarian Res 2011; 4: 17.
Wang C, Mayer JA, Mazumdar A et al. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol Endocrinol 2011; 25: 1527-1538.
Altuvia Y, Landgraf P, Lithwick G et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 2005; 33: 2697-2706.
Parikh A, Lee C, Joseph P et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun 2014; 5: 2977.
Jimenez-Wences H, Peralta-Zaragoza O, Fernandez-Tilapa G. Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). Oncol Rep 2014; 31: 2467-2476.
Vogt M, Butz K, Dymalla S, Semzow J, Hoppe-Seyler F. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene 2006; 25: 4009-4015.
Yu J, Wang Y, Dong R, Huang X, Ding S, Qiu H. Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 2012; 138: 671-674.
Sylvestre Y, De Guire V, Querido E et al. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 2007; 282: 2135-2143.
He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 2006; 26: 8191-8201.
2010; 12
1993; 67
2013; 1
2013; 129
2013; 287
2011; 11
2009; 112
2005; 65
2012; 18
2008; 1
2013; 8
2014; 211
2014; 135
1997; 8
2009; 12
2014; 5
2006; 20
2015; 290
2013; 14
2014; 3
1993; 75
2006; 25
2006; 26
1999; 57
1999; 96
2009; 284
2013; 153
2011; 25
2014; 9
2012; 23
2008; 110
2012; 138
2005; 33
2003; 42
2007; 282
2005; 435
2002; 76
2006; 18
2011; 4
2014; 111
2010; 82
2009; 36
2007; 310
2012; 153
2016; 1
2015; 61
2001; 8
1989; 243
2013; 30
2015; 593
2012; 7
2008; 132
2008; 82
2006; 342
2006; 103
2007; 48
2014; 31
2009; 106
e_1_2_10_23_1
Berezutskaya E (e_1_2_10_32_1) 1997; 8
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
Tanzer A (e_1_2_10_4_1) 2006; 342
e_1_2_10_2_1
e_1_2_10_18_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_55_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_57_1
e_1_2_10_58_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_25_1
e_1_2_10_48_1
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
Gao M (e_1_2_10_41_1) 2008; 1
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_56_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_59_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_31_1
e_1_2_10_50_1
e_1_2_10_60_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_26_1
e_1_2_10_47_1
References_xml – volume: 243
  start-page: 934
  year: 1989
  end-page: 937
  article-title: The human papilloma virus‐16 E7 oncoprotein is able to bind to the retinoblastoma gene product
  publication-title: Science
– volume: 96
  start-page: 6999
  year: 1999
  end-page: 7004
  article-title: Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130
  publication-title: Proc Natl Acad Sci U S A
– volume: 11
  start-page: 708
  year: 2011
  end-page: 713
  article-title: Ovarian cancer stem cells and inflammation
  publication-title: Cancer Biol Ther
– volume: 67
  start-page: 2521
  year: 1993
  end-page: 2528
  article-title: Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation
  publication-title: J Virol
– volume: 14
  start-page: 297
  year: 2013
  end-page: 306
  article-title: Molecular mechanisms underlying RB protein function
  publication-title: Nat Rev Mol Cell Biol
– volume: 112
  start-page: 55
  year: 2009
  end-page: 59
  article-title: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real‐time PCR platform
  publication-title: Gynecol Oncol
– volume: 65
  start-page: 9628
  year: 2005
  end-page: 9632
  article-title: A polycistronic microRNA cluster, miR‐17‐92, is overexpressed in human lung cancers and enhances cell proliferation
  publication-title: Cancer Res
– volume: 25
  start-page: 1527
  year: 2011
  end-page: 1538
  article-title: Estrogen induces c‐myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP‐1 transcription factor
  publication-title: Mol Endocrinol
– volume: 7
  start-page: e35158
  year: 2012
  article-title: Prognostic significance of miR‐205 in endometrial cancer
  publication-title: PLoS One
– volume: 33
  start-page: 2697
  year: 2005
  end-page: 2706
  article-title: Clustering and conservation patterns of human microRNAs
  publication-title: Nucleic Acids Res
– volume: 284
  start-page: 13355
  year: 2009
  end-page: 13362
  article-title: TEAD transcription factors mediate the function of TAZ in cell growth and epithelial‐mesenchymal transition
  publication-title: J Biol Chem
– volume: 3
  start-page: 14
  year: 2014
  article-title: Circulating MicroRNAs in gynecological malignancies: From detection to prediction
  publication-title: Exp Hematol Oncol
– volume: 287
  start-page: 1187
  year: 2013
  end-page: 1204
  article-title: Ovarian epithelial tumors and reproductive factors: A systematic review
  publication-title: Arch Gynecol Obstet
– volume: 5
  start-page: 2977
  year: 2014
  article-title: microRNA‐181a has a critical role in ovarian cancer progression through the regulation of the epithelial‐mesenchymal transition
  publication-title: Nat Commun
– volume: 20
  start-page: 515
  year: 2006
  end-page: 524
  article-title: Control of translation and mRNA degradation by miRNAs and siRNAs
  publication-title: Genes Dev
– volume: 211
  start-page: 627e1
  year: 2014
  end-page: 627e9
  article-title: The influence of comorbid conditions on racial disparities in endometrial cancer survival
  publication-title: Am J Obstet Gynecol
– volume: 153
  start-page: 836
  year: 2013
  end-page: 847
  article-title: MicroRNA‐497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin‐like growth factor 1 receptor
  publication-title: Surgery
– volume: 76
  start-page: 12162
  year: 2002
  end-page: 12172
  article-title: The human papillomavirus type 16 E5 protein impairs TRAIL‐ and FasL‐mediated apoptosis in HaCaT cells by different mechanisms
  publication-title: J Virol
– volume: 82
  start-page: 791
  year: 2010
  end-page: 801
  article-title: Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium
  publication-title: Biol Reprod
– volume: 138
  start-page: 671
  year: 2012
  end-page: 674
  article-title: Circulating microRNA‐218 was reduced in cervical cancer and correlated with tumor invasion
  publication-title: J Cancer Res Clin Oncol
– volume: 8
  start-page: 1277
  year: 1997
  end-page: 1286
  article-title: Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
  publication-title: Cell Growth Differ
– volume: 110
  start-page: 13
  year: 2008
  end-page: 21
  article-title: MicroRNA signatures of tumor‐derived exosomes as diagnostic biomarkers of ovarian cancer
  publication-title: Gynecol Oncol
– volume: 61
  start-page: 1138
  year: 2015
  end-page: 1155
  article-title: Current state of circulating microRNAs as cancer biomarkers
  publication-title: Clin Chem
– volume: 8
  start-page: e70202
  year: 2013
  article-title: Identification and validation of human papillomavirus encoded microRNAs
  publication-title: PLoS One
– volume: 4
  start-page: 17
  year: 2011
  article-title: MicroRNA signature of cis‐platin resistant vs. cis‐platin sensitive ovarian cancer cell lines
  publication-title: J Ovarian Res
– volume: 106
  start-page: 15732
  year: 2009
  end-page: 15737
  article-title: The estrogen receptor‐alpha‐induced microRNA signature regulates itself and its transcriptional response
  publication-title: Proc Natl Acad Sci U S A
– volume: 30
  start-page: 751
  year: 2013
  end-page: 756
  article-title: Estrogen and estrogen receptor induce matrix metalloproteinase‐26 expression in endometrial carcinoma cells
  publication-title: Oncol Rep
– volume: 12
  start-page: 281
  year: 2009
  end-page: 290
  article-title: Human papillomaviruses: Genetic basis of carcinogenicity
  publication-title: Public Health Genomics
– volume: 129
  start-page: 199
  year: 2013
  end-page: 208
  article-title: MicroRNA‐182 plays an onco‐miRNA role in cervical cancer
  publication-title: Gynecol Oncol
– volume: 18
  start-page: 1464
  year: 2012
  end-page: 1471
  article-title: Pathway‐specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer
  publication-title: Clin Cancer Res
– volume: 8
  start-page: 206
  year: 2001
  end-page: 213
  article-title: The expression of HPV‐16 E5 protein in squamous neoplastic changes in the uterine cervix
  publication-title: J Biomed Sci
– volume: 25
  start-page: 4009
  year: 2006
  end-page: 4015
  article-title: Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein
  publication-title: Oncogene
– volume: 23
  start-page: 223
  year: 2012
  end-page: 233
  article-title: miRNAs and estrogen action
  publication-title: Trends Endocrinol Metab
– volume: 593
  start-page: 1777
  year: 2015
  end-page: 1784
  article-title: Vascular and circulating microRNAs in renal ischaemia‐reperfusion injury
  publication-title: J Physiol
– volume: 42
  start-page: 4909
  year: 2003
  end-page: 4917
  article-title: Domain substructure of HPV E6 oncoprotein: Biophysical characterization of the E6 C‐terminal DNA‐binding domain
  publication-title: Biochemistry
– volume: 310
  start-page: 442
  year: 2007
  end-page: 453
  article-title: Transgenic over‐expression of the microRNA miR‐17‐92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells
  publication-title: Dev Biol
– volume: 1
  start-page: 12
  year: 2013
  article-title: Prognostic significance of miR‐194 in endometrial cancer
  publication-title: Biomark Res
– volume: 132
  start-page: 875
  year: 2008
  end-page: 886
  article-title: Targeted deletion reveals essential and overlapping functions of the miR‐17 through 92 family of miRNA clusters
  publication-title: Cell
– volume: 48
  start-page: 410
  year: 2007
  end-page: 412
  article-title: Concomitant MYC and microRNA cluster miR‐17‐92 (C13orf25) amplification in human mantle cell lymphoma
  publication-title: Leuk Lymphoma
– volume: 342
  start-page: 335
  year: 2006
  end-page: 350
  article-title: Evolution of microRNAs
  publication-title: Methods Mol Biol
– volume: 9
  start-page: e90810
  year: 2014
  article-title: Estrogen regulates the tumour suppressor MiRNA‐30c and its target gene, MTA‐1, in endometrial cancer
  publication-title: PLoS One
– volume: 135
  start-page: 371
  year: 2014
  end-page: 381
  article-title: Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: 'When sweet turns sour'
  publication-title: Gynecol Oncol
– volume: 14
  start-page: 2289
  year: 2013
  end-page: 2293
  article-title: Aberrant expression of miR‐20a and miR‐203 in cervical cancer
  publication-title: Asian Pac J Cancer Prev
– volume: 435
  start-page: 828
  year: 2005
  end-page: 833
  article-title: A microRNA polycistron as a potential human oncogene
  publication-title: Nature
– volume: 290
  start-page: 17724
  year: 2015
  end-page: 17732
  article-title: Deciphering the BRCA1 tumor suppressor network
  publication-title: J Biol Chem
– volume: 82
  start-page: 11568
  year: 2008
  end-page: 11576
  article-title: Cell‐restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc
  publication-title: J Virol
– volume: 36
  start-page: 340
  year: 2009
  end-page: 347
  article-title: Maturation of microRNA is hormonally regulated by a nuclear receptor
  publication-title: Mol Cell
– volume: 1
  year: 2016
  article-title: Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer
  publication-title: Cochrane Database Syst Rev
– volume: 26
  start-page: 8191
  year: 2006
  end-page: 8201
  article-title: Mir‐17‐5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA
  publication-title: Mol Cell Biol
– volume: 1
  start-page: 917
  year: 2008
  end-page: 924
  article-title: Different biological effect of estrogen receptor‐related receptor alpha in estrogen receptor‐positive and ‐negative endometrial carcinoma
  publication-title: Mol Med Rep
– volume: 57
  start-page: 211
  year: 1999
  end-page: 215
  article-title: IL‐6, M‐CSF and IAP cytokines in ovarian cancer: Simultaneous assessment of serum levels
  publication-title: Oncology
– volume: 18
  start-page: 39
  year: 2006
  end-page: 48
  article-title: Colony‐stimulating factor‐1 in immunity and inflammation
  publication-title: Curr Opin Immunol
– volume: 111
  start-page: 4262
  year: 2014
  end-page: 4267
  article-title: microRNAs are biomarkers of oncogenic human papillomavirus infections
  publication-title: Proc Natl Acad Sci U S A
– volume: 12
  start-page: 982
  year: 2010
  end-page: 992
  article-title: Bmi1 is essential in Twist1‐induced epithelial‐mesenchymal transition
  publication-title: Nat Cell Biol
– volume: 153
  start-page: 1593
  year: 2012
  end-page: 1602
  article-title: Minireview: Human ovarian cancer: Biology, current management, and paths to personalizing therapy
  publication-title: Endocrinology
– volume: 282
  start-page: 2135
  year: 2007
  end-page: 2143
  article-title: An E2F/miR‐20a autoregulatory feedback loop
  publication-title: J Biol Chem
– volume: 75
  start-page: 495
  year: 1993
  end-page: 505
  article-title: The HPV‐16 E6 and E6‐AP complex functions as a ubiquitin‐protein ligase in the ubiquitination of p53
  publication-title: Cell
– volume: 103
  start-page: 9136
  year: 2006
  end-page: 9141
  article-title: microRNAs exhibit high frequency genomic alterations in human cancer
  publication-title: Proc Natl Acad Sci U S A
– volume: 31
  start-page: 2467
  year: 2014
  end-page: 2476
  article-title: Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review)
  publication-title: Oncol Rep
– ident: e_1_2_10_46_1
  doi: 10.1186/2050-7771-1-12
– ident: e_1_2_10_7_1
  doi: 10.1038/nature03552
– ident: e_1_2_10_27_1
  doi: 10.1016/0092-8674(93)90384-3
– ident: e_1_2_10_31_1
  doi: 10.1128/jvi.67.5.2521-2528.1993
– ident: e_1_2_10_34_1
  doi: 10.1038/nrm3567
– ident: e_1_2_10_43_1
  doi: 10.1016/j.molcel.2009.08.017
– ident: e_1_2_10_28_1
  doi: 10.1038/sj.onc.1209429
– ident: e_1_2_10_35_1
  doi: 10.1073/pnas.1401430111
– ident: e_1_2_10_3_1
  doi: 10.1093/nar/gki567
– ident: e_1_2_10_49_1
  doi: 10.1210/me.2011-1037
– ident: e_1_2_10_37_1
  doi: 10.1016/j.surg.2012.12.004
– ident: e_1_2_10_42_1
  doi: 10.3892/or.2013.2527
– ident: e_1_2_10_39_1
  doi: 10.1074/jbc.M900843200
– ident: e_1_2_10_5_1
  doi: 10.1016/j.cell.2008.02.019
– ident: e_1_2_10_33_1
  doi: 10.1073/pnas.96.12.6999
– volume: 342
  start-page: 335
  year: 2006
  ident: e_1_2_10_4_1
  article-title: Evolution of microRNAs
  publication-title: Methods Mol Biol
  contributor:
    fullname: Tanzer A
– ident: e_1_2_10_23_1
  doi: 10.1159/000214919
– ident: e_1_2_10_24_1
  doi: 10.1007/BF02256414
– ident: e_1_2_10_52_1
  doi: 10.1080/10428190601059738
– ident: e_1_2_10_56_1
  doi: 10.1186/2162-3619-3-14
– ident: e_1_2_10_53_1
  doi: 10.1371/journal.pone.0035158
– ident: e_1_2_10_47_1
  doi: 10.1038/ncb2099
– ident: e_1_2_10_14_1
  doi: 10.1007/s00404-013-2784-1
– ident: e_1_2_10_6_1
  doi: 10.1074/jbc.M608939200
– ident: e_1_2_10_44_1
  doi: 10.1016/j.tem.2012.03.002
– ident: e_1_2_10_51_1
  doi: 10.1016/j.ydbio.2007.08.007
– ident: e_1_2_10_36_1
  doi: 10.1016/j.ygyno.2012.12.043
– ident: e_1_2_10_45_1
  doi: 10.1371/journal.pone.0090810
– ident: e_1_2_10_26_1
  doi: 10.1021/bi026980c
– ident: e_1_2_10_2_1
  doi: 10.1101/gad.1399806
– ident: e_1_2_10_20_1
  doi: 10.1038/ncomms3977
– ident: e_1_2_10_13_1
  doi: 10.1074/jbc.R115.667931
– volume: 8
  start-page: 1277
  year: 1997
  ident: e_1_2_10_32_1
  article-title: Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
  publication-title: Cell Growth Differ
  contributor:
    fullname: Berezutskaya E
– ident: e_1_2_10_38_1
  doi: 10.1371/journal.pone.0070202
– ident: e_1_2_10_54_1
  doi: 10.1113/JP270318
– ident: e_1_2_10_55_1
  doi: 10.1373/clinchem.2015.241190
– ident: e_1_2_10_30_1
  doi: 10.1126/science.2537532
– ident: e_1_2_10_17_1
  doi: 10.1016/j.coi.2005.11.006
– ident: e_1_2_10_25_1
  doi: 10.1128/JVI.76.23.12162-12172.2002
– ident: e_1_2_10_58_1
  doi: 10.1016/j.ygyno.2008.08.036
– ident: e_1_2_10_15_1
  doi: 10.1210/en.2011-2123
– ident: e_1_2_10_11_1
  doi: 10.1002/14651858.CD011732.pub2
– ident: e_1_2_10_21_1
  doi: 10.1158/1078-0432.CCR-11-2485
– ident: e_1_2_10_50_1
  doi: 10.1095/biolreprod.109.081059
– ident: e_1_2_10_40_1
  doi: 10.1016/j.ajog.2014.06.036
– ident: e_1_2_10_60_1
  doi: 10.7314/APJCP.2013.14.4.2289
– ident: e_1_2_10_48_1
  doi: 10.1073/pnas.0906947106
– ident: e_1_2_10_59_1
  doi: 10.1007/s00432-012-1147-9
– ident: e_1_2_10_16_1
  doi: 10.4161/cbt.11.8.14967
– volume: 1
  start-page: 917
  year: 2008
  ident: e_1_2_10_41_1
  article-title: Different biological effect of estrogen receptor‐related receptor alpha in estrogen receptor‐positive and ‐negative endometrial carcinoma
  publication-title: Mol Med Rep
  contributor:
    fullname: Gao M
– ident: e_1_2_10_19_1
  doi: 10.1186/1757-2215-4-17
– ident: e_1_2_10_12_1
  doi: 10.1016/j.ygyno.2014.08.023
– ident: e_1_2_10_29_1
  doi: 10.1128/JVI.01318-08
– ident: e_1_2_10_8_1
  doi: 10.1158/0008-5472.CAN-05-2352
– ident: e_1_2_10_9_1
  doi: 10.1073/pnas.0508889103
– ident: e_1_2_10_57_1
  doi: 10.1016/j.ygyno.2008.04.033
– ident: e_1_2_10_18_1
  doi: 10.1159/000012033
– ident: e_1_2_10_10_1
  doi: 10.1128/MCB.00242-06
– ident: e_1_2_10_22_1
  doi: 10.3892/or.2014.3142
SSID ssj0017918
Score 2.2652638
SecondaryResourceType review_article
Snippet Aim Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of...
Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of gynecologic...
Abstract Aim Gynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of...
AIMGynecologic malignancies are serious problems in female health. Here we aim to discuss the involvement of microRNA (miRNA) in the pathogenesis of...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 612
SubjectTerms Biomarkers - blood
cervical cancer
endometrial cancer
Endometrial Neoplasms - diagnosis
Endometrial Neoplasms - genetics
Endometrial Neoplasms - metabolism
Female
Genital Neoplasms, Female - diagnosis
Genital Neoplasms, Female - genetics
Genital Neoplasms, Female - metabolism
Humans
MicroRNAs - genetics
MicroRNAs - metabolism
miRNA
ovarian cancer
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - genetics
Uterine Cervical Neoplasms - metabolism
Title MicroRNA and gynecologic cancers
URI https://api.istex.fr/ark:/67375/WNG-7ZG849VP-R/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.12995
https://www.ncbi.nlm.nih.gov/pubmed/27098274
https://search.proquest.com/docview/1793569771
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFH6IgnhxX-pGFREvHaZpmkzwJC4jwowyuCFCSJt0DgMdmQXUX29eOi0qCuKthzQkb_2SvHwBOLA5ya51dBgkNh0ENNM0EIaTgPIkYfVIpJnbh2y12eUdvXqMH6fguLwLU_BDVBtu6BkuXqODq2T42cn73ZpNVgIvmIcRx3Kus05FHYWsm-4anI3SSLjLJqxCroqn_PNLLppBsb7-BDS_4laXeC4W4LkcclFv0quNR0ktff_G5vjPOS3C_ASQ-ieFBS3BlMmXYbY1OXJfAb-FJXud9omvcu1333KTFvHST9FgBsNVuLs4vz29DCbPKgQpjaM4iCOhE0KZjqkmjNeZEkZZpWhKTKobhhETa6qQNSahUYpNMzzetOqz4NHUozWYzvu52QA_CzNKOMcHsBQ1SPWSUWUEE4pxHhLlwX4pYPlSsGfIatXR70o3Vw8OneirFmrQw3IzHsuHdlPyp2aDivsb2fFgr9SNtE6AJxsqN_3xUGKUiZmFsqEH64XSqt4Ir4uGtUcPjpzofx-IvLpuuo_NvzfdgjkLoUixKbMN06PB2OxYmDJKdp09fgDmDN4B
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZSyMxGP_wAPVlPVbdWa9xEfFlSjuTowFfxKP1aFeKRxEkZCaZPgjTpbag_vXmy3QGXRTEt3nIhOQ7f0m-_AKwY3OSXevoWhDbdBCQVJNAGB4GhMcxq0YiSd0-ZKvNmtfkrEu7E7Bf3IXJ-SHKDTf0DBev0cFxQ_qtl_d7FZutBJ2EaevuET7ccNQpyaOQd9NdhLNxGil32ZhXyNXxFL--y0bTKNinj6Dme-TqUs_JPNwXg84rTh4qo2FcSV7-43P87qwW4McYk_oHuREtwoTJlmCmNT51_wl-C6v2Ou0DX2Xa7z1nJslDpp-gzQwel-H65PjqsBmMX1YIEkIjGtBI6DgkTFOiQ8arTAmjrF40CU2i64aFhmqikDgmJlGCTVM84bQatPjRVKMVmMr6mfkFflpLScg5voGliEG2l5QoI5hQjPNaqDz4U0hY_ssJNGS58Oj3pJurB7tO9mULNXjAijNO5W27Ifldo07EzaXseLBdKEdaP8DDDZWZ_uhRYqChzKLZmgerudbK3kJeFXVrkh7sOdl_PhB59rfhPn5_vekWzDavWhfy4rR9vgZzFlGxvJZsHaaGg5HZsKhlGG8643wF0lDiIg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD5MB8MX75d6rSLiS8fW5rLgk6ibTjfHcCoihLRJ9yB0MjdQf71JuhYVBfGtD2lIzvVLcvIFYF_nJL3WkVUv1OnAQ7FEHlPU9xANQ1IJWBTbfchWm5z3UPMe3xfgKLsLk_JD5BtuxjNsvDYO_izjz04-6Jd1smJ4CoqIaORrEFE3544ytJv2HpwO04Zxl0xohWwZT_brl2RUNHJ9_QlpfgWuNvPU5-AxG3NacPJUHo_CcvT-jc7xn5Oah9kJInWPUxNagIJKFqHUmpy5L4HbMjV73faxKxLp9t8SFaUB042MxQxflqFXP7s5Ofcm7yp4EcIB9nDAZOgjIjGSPqEVIpgSWisS-SqSNUV8hSUShjYmREFkmsbmfFPrT6NHVQlWYDoZJGoN3LgaI59S8wKWQMpwvcRIKEaYIJRWfeHAXiZg_pzSZ_B82THocztXBw6s6PMWYvhk6s0o5nftBqcPjRpitx3edWA30w3XXmCONkSiBuMXbsIMJhrLVh1YTZWW9-bTCqtpg3Tg0Ir-94Hw5nXDfqz_vekOlDqndX510b7cgBkNp0haSLYJ06PhWG1pyDIKt61pfgA_l-DR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA+and+gynecologic+cancers&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Kanekura%2C+Kohsuke&rft.au=Nishi%2C+Hirotaka&rft.au=Isaka%2C+Keiichi&rft.au=Kuroda%2C+Masahiko&rft.date=2016-06-01&rft.eissn=1447-0756&rft.volume=42&rft.issue=6&rft.spage=612&rft.epage=617&rft_id=info:doi/10.1111%2Fjog.12995&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon